Skip to main content
Screener/Healthcare/Biotechnology

CORT — Corcept Therapeutics Incorporated

NASDAQ
$80.07+0.36 (+0.45%)
Mid CapHealthcareLow Beta
$28.66
$91.00
$79.22
$82.31
EPS (TTM)$0.35
P/E Ratio227.60
Dividend Yield—
Market Cap$8.58B
Volume570K
Prev Close$79.71
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$164.9M-$31.2M$-0.3098.3%-18.9%
Q4 '25$202.1M$24.3M$0.2098.7%12.0%
Q3 '25$207.6M$19.4M$0.1697.8%9.3%
Q2 '25$194.4M$35.1M$0.2998.2%18.1%
Q1 '25$157.2M$20.3M$0.1798.5%12.9%
Q4 '24$181.9M$30.4M$0.2698.4%16.7%
Q3 '24$182.5M$46.7M$0.4198.4%25.6%
Q2 '24$163.8M$35.5M$0.3298.5%21.7%
Get Your Daily Market Recap